SI
Sofinnova Investments’s Axsome Therapeutics AXSM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.77M | Sell |
93,610
-81,707
| -47% | -$8.53M | 0.6% | 38 |
|
|
2025
Q1 | $20.4M | Sell |
175,317
-316,409
| -64% | -$36.9M | 1.34% | 25 |
|
|
2024
Q4 | $41.6M | Buy |
491,726
+112,199
| +30% | +$9.49M | 3.03% | 10 |
|
|
2024
Q3 | $34.1M | Buy |
379,527
+69,329
| +22% | +$6.23M | 2.71% | 11 |
|
|
2024
Q2 | $25M | Buy |
+310,198
| New | +$25M | 1.3% | 21 |
|
|
2023
Q4 | – | Sell |
-80,368
| Closed | -$5.62M | – | 62 |
|
|
2023
Q3 | $5.62M | Sell |
80,368
-98,874
| -55% | -$6.91M | 0.35% | 37 |
|
|
2023
Q2 | $12.9M | Buy |
179,242
+58,346
| +48% | +$4.19M | 0.84% | 28 |
|
|
2023
Q1 | $7.46M | Buy |
+120,896
| New | +$7.46M | 0.48% | 36 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 59 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 64 |
|
|
2020
Q3 | – | Sell |
-86,978
| Closed | -$7.16M | – | 66 |
|
|
2020
Q2 | $7.16M | Buy |
86,978
+13,815
| +19% | +$1.14M | 0.45% | 38 |
|
|
2020
Q1 | $4.3M | Buy |
+73,163
| New | +$4.3M | 0.4% | 34 |
|